logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

FAMEGLOW (03774) to resume trading on November 2

date
08:49 02/11/2026
avatar
GMT Eight
FAMEGLOW (03774) announces that trading in the Company's shares will resume at 9:00 a.m. on November 2, 2026.
FAMEGLOW (03774) announced that trading in its shares will resume at 9:00 a.m. on November 2, 2026.
Related Articles
HK Stock Market Move | Chinese brokerage stocks rise collectively; three government departments reportedly meet with financial institutions today; institutions say brokerage valuations are severely mismatched with profitability.
China Stock
A-share Market Open Brief | All three major indices open higher; consumer and brokerage sectors strengthen
China Stock
Sinolink: Savolitinib reaches a value inflection point, with global commercialization set to begin in 2027.
HK Stock Market Move | Chinese brokerage stocks rise collectively; three government departments reportedly meet with financial institutions today; institutions say brokerage valuations are severely mismatched with profitability.
A-share Market Open Brief | All three major indices open higher; consumer and brokerage sectors strengthen
China Stock
Sinolink: Savolitinib reaches a value inflection point, with global commercialization set to begin in 2027.
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.